肿瘤患者的心血管磁共振检查
该报告描述了心血管磁共振在肿瘤患者或曾接受肿瘤治疗患者中的应用。此类患者可能发生左心室质量、舒张功能或收缩功能下降,也可能出现瓣膜性心脏病、心包疾病或心内肿块。心血管磁共振可评估心脏解剖、结构和功能,并表征心肌组织,有助于诊断和管理这些患者的心血管疾病。
要点
- 肿瘤治疗患者可能发生左心室质量、舒张功能或收缩功能下降。
- 患者也可能出现瓣膜性心脏病、心包疾病或心内肿块。
- 心血管磁共振可评估心脏解剖、结构、功能并表征心肌组织。
核心结论
- 心血管磁共振可评估心脏解剖、结构和功能并表征心肌组织,有助于诊断和管理肿瘤患者或曾接受肿瘤治疗患者的心血管疾病。
研究设计与样本
- 该报告为对既往研究的概述,描述了心血管磁共振用于评估肿瘤患者或曾接受肿瘤治疗患者心血管疾病的研究。
临床应用与阅片要点
- 心血管磁共振可用于评估肿瘤患者或曾接受肿瘤治疗患者的心脏解剖、结构和功能,并表征心肌组织。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic resonance may be used to assess cardiac anatomy, structure, and function and to characterize myocardial tissue. This combination of features facilitates the diagnosis and management of disease processes in patients with or those who have survived cancer. This report outlines and describes prior research involving cardiovascular magnetic resonance for assessing cardiovascular disease in patients with or previously having received treatment for cancer.
引用
- Jordan JH, Todd RM, Vasu S, et al. Cardiovascular Magnetic Resonance in the Oncology Patient. JACC Cardiovasc Imaging. 2018. PMID: 30092971. doi:10.1016/j.jcmg.2018.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。